|Description||This active molecular is an potential cognitive enhancer originated by Bristol-Myers Squibb. Mechanism of Action is not identified. Bmy 21502 is also a nootropic agent and it can protect rodents from ECS-induced amnesia in a step-down passive avoidance task. But clinical study for treatment of Alzheimer's disease was discontinued.|
|Synonyms||Bmy 21502; Bmy21502; Bmy-21502; Bms-181168; Bms 181168; Bms181168. 1-((1-(2-(trifluoromethyl)pyrimidin-4-yl)piperidin-4-yl)methyl)pyrrolidin-2-one|
|Solubility||Soluble in DMSO|
|Quality Standard||In-house standard|
|Shelf Life||2 month in rt, long time|
|Current Developer||Originator:Bristol-Myers Squibb|
ITX3 is a specific inhibitor of endogenous TrioN activity acting on the GEF domain and selective cell active inhibitor of the Trio/RhoG/Rac1 pathway. The compou...
CI 976 has been found to be a selective inhibitor of Acyl-coenzyme A and could probably lower non-high density lipoprotein (HDL)-cholesterol.
Afoxolaner is a potent isoxazoline insecticide and acaricide against Ixodes scapularis in dogs. It is indicated for the treatment and prevention of flea infesta...
Remimazolam, a benzodiazepine derivative, an ultra-short-acting intravenous benzodiazepine sedative/anesthetic, currently in Phase III clinical development for ...
Decynium 22 is a potent inhibitor of PMAT and has been found to exhibit activities in inducing apoptosis in cerebellar granule neurons (CGNs).
Atosiban, a nonapeptide, desamino-oxytocin analogue, is a competitive inhibitor of the hormones oxytocin and vasopressinv. It inhibits the oxytocin-mediated rel...
Glycodiazine is a sulfapyrimidine derivative with antihyperglycemic activity used in biological activities to predict human intestinal absorption in drug discov...
Lomitapide Mesylate is a potent microsomal triglyceride transfer protein (MTP) inhibitor, used in the treatment of familial hypercholesterolemia.